-
公开(公告)号:US11098054B2
公开(公告)日:2021-08-24
申请号:US16628768
申请日:2018-07-05
Applicant: The United States of America,as represented by the Secretary,Department of Health and Human Services , Fundacio Institut Catala D'Investigacio Quimica , University of Delaware , University of Leeds , Universitat Rovira I Virgili
Inventor: John A. Beutler , Antonio Echavarren , William Chain , David Beech , Zhenhua Wu , Jean-Simon Suppo , Fernando Bravo , Hussein Rubaiy
IPC: C07D493/08 , A61P35/00 , C07D495/08 , C07D471/08
Abstract: Disclosed is a compound of formula (I) in which a, R1-R5 and X1 are as described herein. Also disclosed are a pharmaceutical composition containing the compound and a method of using the compound for treating cancer, such as renal cancer.
-
公开(公告)号:US10591493B2
公开(公告)日:2020-03-17
申请号:US15543151
申请日:2015-07-28
Applicant: FUNDACIO INSTITUT CATALA D'INVESTIGACIO QUIMICA (ICIQ) , INSTITUCIO CATALANA DE RECERCA I ESTUDIS AVANCATS , UNIVERSITAT ROVIRA I VIRGILI
Inventor: Louis Adriaenssens , Pau Ballester , Francisco Javier Andrade , Pascal Blondeau , Francesc Xavier Rius , Tomas De Aquino Guinovart Pavon , Daniel Hernandez Alonso
IPC: G01N33/00 , G01N33/70 , C07D403/14 , C07D487/22 , B01J39/16 , C07D491/22 , C07F9/6571 , C08J5/22 , C08K5/32 , C08K5/5373 , C08K5/55 , G01N27/40
Abstract: Compounds are of the formula (Ia), (Ib), (Ic), or are stereoisomers thereof, wherein: R1 is hydrogen, (C1-C20)alkyl; (C3-C20)alkenyl; (C3 C20)alkynyl; (C1-C6)alkyl-O—; (C3-C20)cycloalkyl; (C1 C20)haloalkyl; (C6-C20)aryl optionally substituted; (C6-C20)heteroaryl optionally substituted; R2 and R2′ are hydrogen; (C1-C20)alkyl; (C1-C6)alkyl-O—; (C1-C6)haloalkyl; halogen; cyano; and nitro; Z1 to Z4 are diradicals of formula (III) wherein A1 and A2 are O— or NR3-, wherein R3 is selected from the group consisting of hydrogen and (C1-C20)alkyl; and G is (C1-C6)alkyl; —P(═S)R5-; —P(═O)R4; —P(═O)(OR4)-; —P(═O)(NR6R7)-; —S(═O)2-; S(═O)—; or —C(═O)—; and Y1 to Y4 are (C1-C8)alkyl; (C3-C7)cycloalkyl; (C6-C20)aryl optionally substituted; or (C6-C20)heteroaryl optionally substituted; and FG1 and FG2 are H, OH, or NHR8.
-
公开(公告)号:US09676795B2
公开(公告)日:2017-06-13
申请号:US14000116
申请日:2012-02-17
Applicant: Vladimir Grushin , Alessandro Zanardi
Inventor: Vladimir Grushin , Alessandro Zanardi
CPC classification number: C07F1/08 , C07B39/00 , C07C17/32 , C07C41/30 , C07C45/455 , C07C45/68 , C07C201/12 , C07F1/005 , C07C22/08 , C07C205/11 , C07C43/225 , C07C49/80
Abstract: Process to obtain a trifluoromethylating composition which comprises the reaction between a copper (I) source and a base in the presence of a solvent and between the resulting cuprating reagent with fluoroform.
-
4.
公开(公告)号:US10604469B2
公开(公告)日:2020-03-31
申请号:US16320691
申请日:2017-01-13
Inventor: Antonio M. Echavarren , Ruth Dorel , Paul McGonigal
IPC: C07C43/166 , C07D333/16 , C07D333/56 , C07F7/08 , C07C41/18 , C07C25/22 , C07C47/546 , C07C49/84 , C07C43/215 , C07C43/176 , C07C17/361 , C07C45/68 , C07C41/30 , C07C45/64 , C07C45/65 , C07C47/575 , C07C43/21 , C07C13/66 , C07C1/20 , C07C49/792 , C07C13/62 , C07D333/50 , C07C15/38
Abstract: The present invention relates to a process for preparing a partially hydrogenated polyacene, and a novel intermediate used in such process; also the present invention relates to a process for preparing the corresponding conjugated polyacenes.
-
公开(公告)号:US20170370948A1
公开(公告)日:2017-12-28
申请号:US15543151
申请日:2015-07-28
Applicant: FUNDACIO INSTITUT CATALA D'INVESTIGACIO QUIMICA (ICIQ) , INSTITUCIO CATALANA DE RECERCA I ESTUDIS AVANCATS , UNIVERSITAT ROVIRA I VIRGILI
Inventor: Louis ADRIAENSSENS , Pau BALLESTER , Francisco Javier ANDRADE , Pascal BLONDEAU , Francesc Xavier RIUS , Tomas De Aquino GUINOVART PAVON , Daniel HERNANDEZ ALONSO
IPC: G01N33/70 , C08K5/55 , C08K5/5373 , C07D491/22 , B01J39/16 , C08J5/22 , C07F9/6571 , G01N27/40 , C08K5/32
CPC classification number: G01N33/70 , B01J39/16 , C07D403/14 , C07D487/22 , C07D491/22 , C07F9/657181 , C08J5/22 , C08J2327/06 , C08K5/32 , C08K5/5373 , C08K5/55 , G01N27/40
Abstract: Compounds are of the formula (Ia), (Ib), (Ic), or are stereoisomers thereof, wherein: R1 is hydrogen, (C1-C20)alkyl; (C3-C20)alkenyl; (C3 C20)alkynyl; (C1-C6)alkyl-O—; (C3-C20)cycloalkyl; (C1 C20)haloalkyl; (C6-C20)aryl optionally substituted; (C6-C20)heteroaryl optionally substituted; R2 and R2′ are hydrogen; (C1-C20)alkyl; (C1-C6)alkyl-O—; (C1-C6)haloalkyl; halogen;cyano; and nitro; Z1 to Z4 are diradicals of formula (III) wherein Al and A2 are O—or —NR3-, wherein R3 is selected from the group consisting of hydrogen and (C1-C20)alkyl; and G is (C1-C6)alkyl; —P(═S)R5-; —P(═O)R4; P(═O)(OR4)-; —P(═O)(NR6R7)-; —S(=0)2-; S(═O)—; or —C(═O)—; and Y1 to Y4 are (C1-C8)alkyl; (C3-C7)cycloalkyl; (C6-C20)aryl optionally substituted; or (C6-C20)heteroaryl optionally substituted; and FG1 and FG2 are H, OH, or NHR8.
-
-
-
-